Arch Venture Management’s Kura Oncology KURA Stock Holding History

Arch Venture Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-206,307	Closed	-$3.36M	–	4
2020 Q2	$3.36M	Sell	206,307 -200,000	-49%	-$2.88M	11.31%	4
2020 Q1	$4.04M	Hold	406,307	–	–	6.83%	5
2019 Q4	$5.59M	Sell	406,307 -500,000	-55%	-$7.41M	7.28%	5
2019 Q3	$13.7M	Sell	906,307 -450,000	-33%	-$8.01M	15.05%	3
2019 Q2	$26.7M	Sell	1,356,307 -250,000	-16%	-$4.15M	27.65%	2
2019 Q1	$26.6M	Sell	1,606,307 -250,000	-13%	-$3.85M	25.74%	2
2018 Q4	$26.1M	Buy	+1,856,307	New	+$24.6M	26.06%	3

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Arch Venture Management's KURA Position: Q3 2020 in Review

Arch Venture Management sold out of Kura Oncology (KURA) in Q3 2020, closing a stake of 206,307 shares — an estimated $3.36M sold.

Arch Venture Management first reported a position in KURA in Q4 2018 and held it in 7 quarters. The position peaked at $26.7M in Q2 2019. 162 funds tracked by Wall St. Rank hold KURA as of Q3 2020.

Arch Venture Management reported no remaining Kura Oncology position as of Q3 2020 after selling out during the quarter.
Arch Venture Management sold 206,307 Kura Oncology shares in Q3 2020, an estimated $3.36M.
Arch Venture Management first reported a position in Kura Oncology in Q4 2018 and held it in 7 quarters.
Arch Venture Management's Kura Oncology position peaked at $26.7M in Q2 2019.
162 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2020.

Based on Arch Venture Management's 13F filing for Q3 2020, filed 16 Nov 2020.